1. Ma M, Hui J. Progress in the treatment of severe fulminant myocarditis. J Clin Cardiol. 2010;26:83–6.
2. Li Y, Sun L, Guo L. Status and progress of diagnosis and treatment of fulminant myocarditis. Natl Med J China. 2017;97:235–7.
3. The Precision Medicine Group of Chinese Society of Cardiology, the Editorial Board of Chinese Journal of Cardiology, the Working Group on Adult Fulminant Myocarditis. Chinese expert consensus on the diagnosis and treatment of adult fulminant myocarditis. Chin J Cardiol. 2017;45:742–52.
4. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm. 2008;5:e1–62. https://doi.org/10.1016/j.hrthm.2008.04.014.
5. Guo P, Qiu J, Wang Y, Chen G, Proietti R, Fadhle AS, Zhao C, Wen WD. Zero-fluoroscopy permanent pacemaker implantation using Ensite NavX system: clinical viability or fanciful technique? Pacing Clin Electrophysiol. 2018;41:122–7. https://doi.org/10.1111/pace.13248.